Gain Therapeutics
Develops allosteric medicines and rexaceract for Parkinson’s disease.
$1.77
After-hours close0.00 (0.00%)
At close$1.77(−4.32%)
| Date | Estimate | Reported | Surprise |
|---|---|---|---|
| Nov 2026 | −$0.13 | — | — |
| Aug 2026 | −$0.14 | −$0.11 | +20.3% |
| May 2026 | −$0.13 | −$0.13 | 0.0% |
| Mar 2026 | −$0.14 | −$0.11 | +21.4% |
| Nov 2025 | −$0.15 | −$0.15 | 0.0% |
The latest year is open to everyone — the 29 quarters behind it read with an account. Sign in | |||
| Aug 2025 | |||
| May 2025 | |||
| Mar 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Mar 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Mar 2023 | |||
| Nov 2022 | |||
| Aug 2022 | |||
| May 2022 | |||
| Mar 2022 | |||
| Nov 2021 | |||
| Aug 2021 | |||
| May 2021 | |||
| Mar 2021 | |||
| Dec 2020 | |||
| Jun 2020 | |||
| Mar 2020 | |||
| Dec 2019 | |||
| Sep 2019 | |||
| Jun 2019 | |||
| Mar 2019 | |||
| Sep 2018 | |||
| Jun 2018 | |||
| Mar 2018 | |||
| Report date | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise |
|---|---|---|---|---|---|---|
| Nov 11, 2026 | −$0.13 | — | — | $33.3K | — | — |
| Aug 11, 2026 | −$0.14 | −$0.11 | +20.3% | $33.3K | — | — |
| May 11, 2026 | −$0.13 | −$0.13 | 0.0% | $33.3K | — | — |
| Mar 26, 2026 | −$0.14 | −$0.11 | +21.4% | $25.0K | — | — |
| Nov 12, 2025 | −$0.15 | −$0.15 | 0.0% | — | — | — |
The latest year is open to everyone — the 29 quarters behind it read with an account. Sign in | ||||||
| Aug 12, 2025 | ||||||
| May 14, 2025 | ||||||
| Mar 27, 2025 | ||||||
| Nov 14, 2024 | ||||||
| Aug 8, 2024 | ||||||
| May 14, 2024 | ||||||
| Mar 26, 2024 | ||||||
| Nov 14, 2023 | ||||||
| Aug 10, 2023 | ||||||
| May 12, 2023 | ||||||
| Mar 23, 2023 | ||||||
| Nov 10, 2022 | ||||||
| Aug 8, 2022 | ||||||
| May 16, 2022 | ||||||
| Mar 24, 2022 | ||||||
| Nov 12, 2021 | ||||||
| Aug 11, 2021 | ||||||
| May 10, 2021 | ||||||
| Mar 22, 2021 | ||||||
| Dec 31, 2020 | ||||||
| Jun 30, 2020 | ||||||
| Mar 31, 2020 | ||||||
| Dec 31, 2019 | ||||||
| Sep 30, 2019 | ||||||
| Jun 30, 2019 | ||||||
| Mar 31, 2019 | ||||||
| Sep 30, 2018 | ||||||
| Jun 30, 2018 | ||||||
| Mar 31, 2018 | ||||||